Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore

Reference List

• Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8:Suppl S7 - 16; http://dx.doi.org/10.1038/nrmicro2460; PMID: 21079655
   PubMed Web of Science ®Google Scholar
• Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 2010; 12:157 - 64; http://dx.doi.org/10.1007/s11908-010-0102-7; PMID: 21308524
   PubMedGoogle Scholar
• Adams B, Holmes EC, Zhang C, Mammen MP Jr., Nimmannitya S, Kalayanarooj S, et al. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A 2006; 103:14234 - 9; http://dx.doi.org/10.1073/pnas.0602768103; PMID: 16966609
   PubMed Web of Science ®Google Scholar
• Rothman AL. Dengue: defining protective versus pathologic immunity. J Clin Invest 2004; 113:946 - 51; PMID: 15057297
   PubMed Web of Science ®Google Scholar
• Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis 2006; 19:429 - 36; http://dx.doi.org/10.1097/01.qco.0000244047.31135.fa; PMID: 16940865
   PubMed Web of Science ®Google Scholar
• Guy B, Almond JW. Towards a dengue vaccine: progress to date and remaining challenges. Comp Immunol Microbiol Infect Dis 2008; 31:239 - 52; http://dx.doi.org/10.1016/j.cimid.2007.07.011; PMID: 17889365
   PubMed Web of Science ®Google Scholar
• Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 2008; 225:300 - 13; http://dx.doi.org/10.1111/j.1600-065X.2008.00678.x; PMID: 18837790
   PubMed Web of Science ®Google Scholar
• Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 2005; 175:2676 - 83; PMID: 16081844
   PubMed Web of Science ®Google Scholar
• Blaney JE Jr., Durbin AP, Murphy BR, Whitehead SS. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol 2006; 19:10 - 32; http://dx.doi.org/10.1089/vim.2006.19.10; PMID: 16553547
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Arroyo J, Pugachev KV, Miller C, Zhang ZX, Weltzin R, et al. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol 2001; 75:7290 - 304; http://dx.doi.org/10.1128/JVI.75.16.7290-7304.2001; PMID: 11462001
   PubMed Web of Science ®Google Scholar
• Durbin AP, Whitehead SS. Dengue vaccine candidates in development. Curr Top Microbiol Immunol 2010; 338:129 - 43; http://dx.doi.org/10.1007/978-3-642-02215-9_10; PMID: 19802583
   PubMed Web of Science ®Google Scholar
• Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol 2007; 5:518 - 28; http://dx.doi.org/10.1038/nrmicro1690; PMID: 17558424
   PubMed Web of Science ®Google Scholar
• Capeding RZ, Luna IA, Bomasang E, Lupisan S, Lang J, Forrat R, et al. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines. Vaccine 2011; 29:3863 - 72; http://dx.doi.org/10.1016/j.vaccine.2011.03.057; PMID: 21477675
   PubMed Web of Science ®Google Scholar
• Poo J, Galan F, Forrat R, Zambrano B, Lang J, Dayan GH. Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity. Pediatr Infect Dis J 2010; In Press PMID: 21042231
   PubMed Web of Science ®Google Scholar
• Qiao M, Shaw D, Forrat R, Wartel-Tram A, Lang J. Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans. Am J Trop Med Hyg 2011; 85:724 - 31; http://dx.doi.org/10.4269/ajtmh.2011.10-0436; PMID: 21976579
   PubMed Web of Science ®Google Scholar
• Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, Lang J. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. J Infect Dis 2010; 201:370 - 7; http://dx.doi.org/10.1086/649916; PMID: 20059357
   PubMed Web of Science ®Google Scholar
• Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J. From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine 2011; 29:7229 - 41; http://dx.doi.org/10.1016/j.vaccine.2011.06.094; PMID: 21745521
   PubMed Web of Science ®Google Scholar
• Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012; 380:1559 - 67; http://dx.doi.org/10.1016/S0140-6736(12)61428-7; PMID: 22975340
   PubMed Web of Science ®Google Scholar
• Guy B, Nougarede N, Begue S, Sanchez V, Souag N, Carre M, et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 2008; 26:5712 - 21; http://dx.doi.org/10.1016/j.vaccine.2008.08.019; PMID: 18762226
   PubMed Web of Science ®Google Scholar
• Ler TS, Ang LW, Yap GSL, Ng LC, Tai JC, James L, et al. Epidemiological characteristics of the 2005 and 2007 dengue epidemics in Singapore – similarities and distinctions. Western Pacific Surveillance and Response Journal 2011; 2:1 - 6; http://dx.doi.org/10.5365/wpsar.2010.1.1.011
   Google Scholar
• Afonso G, Scotto M, Renand A, Arvastsson J, Vassilieff D, Cilio CM, et al. Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms. J Immunol Methods 2010; 359:28 - 36; http://dx.doi.org/10.1016/j.jim.2010.05.005; PMID: 20641145
   PubMed Web of Science ®Google Scholar
• McKenna KC, Beatty KM, Vicetti Miguel R, Bilonick RA. Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function. J Immunol Methods 2009; 341:68 - 75; http://dx.doi.org/10.1016/j.jim.2008.10.019; PMID: 19041316
   PubMed Web of Science ®Google Scholar
• Leo YS, Wilder-Smith A, Archuleta S, Shek LP, Chong CY, Leong HN, et al. Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore. Hum Vaccin Immunother 2012; 8:1259 - 71; http://dx.doi.org/10.4161/hv.21224; PMID: 22894958
   PubMed Web of Science ®Google Scholar
• Mangada MM, Endy TP, Nisalak A, Chunsuttiwat S, Vaughn DW, Libraty DH, et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 2002; 185:1697 - 703; http://dx.doi.org/10.1086/340822; PMID: 12085313
   PubMed Web of Science ®Google Scholar
• Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19 - 26; http://dx.doi.org/10.1016/0167-5699(94)90021-3; PMID: 7907877
   PubMedGoogle Scholar
• Minty A, Asselin S, Bensussan A, Shire D, Vita N, Vyakarnam A, et al. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Netw 1997; 8:203 - 13; PMID: 9262969
   PubMed Web of Science ®Google Scholar
• Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17:1 - 52; http://dx.doi.org/10.3109/08830189809084486; PMID: 9914942
   PubMedGoogle Scholar
• Bailer RT, Holloway A, Sun J, Margolick JB, Martin M, Kostman J, et al. IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J Immunol 1999; 162:7534 - 42; PMID: 10358209
   PubMed Web of Science ®Google Scholar
• Hoffmann F, Albert MH, Arenz S, Bidlingmaier C, Berkowicz N, Sedlaczek S, et al. Intracellular T-cell cytokine levels are age-dependent in healthy children and adults. Eur Cytokine Netw 2005; 16:283 - 8; PMID: 16464742
   PubMed Web of Science ®Google Scholar